Compare Novo Nordisk A/S (NVO) vs Shopify Inc. (SHOP) Price & Performance

Novo Nordisk A/STrade

Shopify Inc.Trade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Shopify Inc. — how do they compare? Novo Nordisk A/S trades at $45.17 (market cap $200.69B), while Shopify Inc. trades at $127.26 (market cap $172.54B). The key difference: Novo Nordisk A/S is the larger of the two by market cap, and Novo Nordisk A/S pays a 3.98% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals.

	NVO	SHOP
Market Cap	$200.69B	$172.54B
Sector	Health	Technology
52-Week High	$63.98	$179.01
52-Week Low	$35.29	$95.40
Enterprise Value	$215.49B	$167.77B
Dividend Yield	3.98%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $45.16, down 3.09% today, with bearish technical signals but strong fundamentals. The stock shows robust profitability with 35.35% net margin and 59.82% ROE, supported by consistent earnings beats. Recent developments include positive pediatric obesity trial results for semaglutide and Wegovy pill launch in Germany. Cash flow remains healthy with $10.81B net inflow in 2025, though 2026 projections show a decline.

NVO presents a mixed outlook with strong fundamental metrics offset by technical weakness and competitive pressures. Investment opportunity lies in the expanding GLP-1 market and pipeline developments, while risks include market share loss to Eli Lilly and failed cardiovascular drug trials. Analyst consensus leans bullish with 57.9% buy ratings, but recent prescription slowdown concerns warrant caution.

Shopify Inc.

SHOP trades at $134.1, down 7.57% in the past 24 hours, reflecting recent market pressure. The stock is near its 52-week low of $130.00, with technical indicators showing a bearish trend. Fundamentally, revenue grew to $11.56B in 2025, but the P/E ratio of 90.61 suggests a premium valuation. Recent news highlights AI initiatives and competitive comparisons, while earnings show mixed quarterly results with a miss in Q4 2025 but beats in Q1 and Q2 2026.

Outlook: Strong revenue growth and expanding gross merchandise volume support long-term potential, but high valuation and recent price decline pose near-term risks. Analyst consensus is bullish with a $167.50 price target, though competitive pressures and market volatility require careful monitoring for investors.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVO

Canada imposes retaliatory tariffs on $20B of U.S. goods, escalating trade tensions and impacting North American supply chains.Seeking Alpha · 2 days agoNeutral 4-Factor Dividend Growth Strategy slightly outperforms SCHD with 14.89% returns, testing new variants.Seeking Alpha · 3 days agoBullish View details →

SHOP

Shopify acquires Tailwind Labs to boost custom storefront and commerce tools for merchantsPYMNTS · 12 hours agoBullish Shopify and Etsy stocks drop sharply while broader e-commerce sector remains stable.24/7 Wall Street · 1 day agoBearish View details →

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About Shopify Inc.

Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.